BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4060148)

  • 1. Structure-activity relationships of putative primaquine metabolites causing methemoglobin formation in canine hemolysates.
    Link CM; Theoharides AD; Anders JC; Chung H; Canfield CJ
    Toxicol Appl Pharmacol; 1985 Nov; 81(2):192-202. PubMed ID: 4060148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative activity of primaquine metabolites on rat erythrocytes in vitro and in vivo.
    Vásquez-Vivar J; Augusto O
    Biochem Pharmacol; 1994 Jan; 47(2):309-16. PubMed ID: 8304975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methemoglobin formation resulting from administration of candidate 8-aminoquinoline antiparasitic drugs in the dog.
    Anders JC; Chung H; Theoharides AD
    Fundam Appl Toxicol; 1988 Feb; 10(2):270-5. PubMed ID: 3356313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simple and rapid evaluation of methemoglobin toxicity of 8-aminoquinolines and related compounds.
    Srivastava P; Singh S; Jain GK; Puri SK; Pandey VC
    Ecotoxicol Environ Saf; 2000 Mar; 45(3):236-9. PubMed ID: 10702341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the mechanisms of oxidation in the erythrocyte by metabolites of primaquine.
    Fletcher KA; Barton PF; Kelly JA
    Biochem Pharmacol; 1988 Jul; 37(13):2683-90. PubMed ID: 2839199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of glucose-6-phosphate dehydrogenase deficient red cells to primaquine enantiomers and two putative metabolites--I. Effect on reduced glutathione, methemoglobin content and release of hemoglobin.
    Agarwal S; Gupta UR; Gupta RC; Anand N; Agarwal SS
    Biochem Pharmacol; 1988 Dec; 37(24):4605-9. PubMed ID: 3202898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of methemoglobin and metmyoglobin using 8-aminoquinoline derivatives or sodium nitrite and subsequent reaction with cyanide.
    Steinhaus RK; Baskin SI; Clark JH; Kirby SD
    J Appl Toxicol; 1990 Oct; 10(5):345-51. PubMed ID: 2254586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methemoglobin toxicity and hematological studies on malaria anti-relapse compound CDRI 80/53 in dogs.
    Puri SK; Srivastava R; Pandey VC; Sethi N; Dutta GP
    Am J Trop Med Hyg; 1989 Dec; 41(6):638-42. PubMed ID: 2641641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxylated metabolites of the antimalarial drug primaquine. Oxidation and redox cycling.
    Vásquez-Vivar J; Augusto O
    J Biol Chem; 1992 Apr; 267(10):6848-54. PubMed ID: 1313024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of 8-aminoquinoline antimalarial agents.
    Strother A; Fraser IM; Allahyari R; Tilton BE
    Bull World Health Organ; 1981; 59(3):413-25. PubMed ID: 6976849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nine synthetic putative metabolites of primaquine on activity of the hexose monophosphate shunt in intact human red blood cells in vitro.
    Baird JK; McCormick GJ; Canfield CJ
    Biochem Pharmacol; 1986 Apr; 35(7):1099-106. PubMed ID: 3754446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox conversions of methemoglobin during redox cycling of quinones and aromatic nitrocompounds.
    Cénas N; Ollinger K
    Arch Biochem Biophys; 1994 Nov; 315(1):170-6. PubMed ID: 7979395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Side-chain hydroxylation in the metabolism of 8-aminoquinoline antiparasitic agents.
    Idowu OR; Peggins JO; Brewer TG
    Drug Metab Dispos; 1995 Jan; 23(1):18-27. PubMed ID: 7720521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies with primaquine in vitro: superoxide radical formation and oxidation of haemoglobin.
    Summerfield M; Tudhope GR
    Br J Clin Pharmacol; 1978 Oct; 6(4):319-23. PubMed ID: 212091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural requirements for the ferrihemoglobin-forming activity of glutathione S-conjugates of 4-dimethylaminophenol.
    Ludwig E; Eyer P
    Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):133-6. PubMed ID: 7889835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DFT study on the radical anions formed by primaquine and its derivatives.
    Liu H; Walker LA; Doerksen RJ
    Chem Res Toxicol; 2011 Sep; 24(9):1476-85. PubMed ID: 21699254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photooxidation products of primaquine. Structure, antimalarial activity and hemolytic effects.
    Brossi A; Gessner W; Hufford CD; Baker JK; Homo F; Millet P; Landau I
    FEBS Lett; 1987 Oct; 223(1):77-81. PubMed ID: 3666145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactions of the Wurster's red radical cation with hemoglobin and glutathione during the cooxidation of N,N-dimethyl-p-phenylenediamine [correction of phenlenediamine] and oxyhemoglobin in human red cells.
    Störle C; Eyer P
    Chem Biol Interact; 1992 Aug; 83(3):271-91. PubMed ID: 1516152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reaction of menadione with haemoglobin. Mechanism and effect of superoxide dismutase.
    Winterbourn CC; French JK; Claridge RF
    Biochem J; 1979 Jun; 179(3):665-73. PubMed ID: 475774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline.
    Bolchoz LJ; Budinsky RA; McMillan DC; Jollow DJ
    J Pharmacol Exp Ther; 2001 May; 297(2):509-15. PubMed ID: 11303037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.